63875-18-3 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 4-amino-1,2,5-thiadiazole-3-carboxylate is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its reactivity and functional group compatibility make it a valuable component in the development of new drugs and medications.
Used in Organic Synthesis:
In the field of organic synthesis, Methyl 4-amino-1,2,5-thiadiazole-3-carboxylate is used as a key building block for the creation of more complex organic molecules. Its unique structure allows for versatile reactions, making it a valuable asset in the synthesis of a wide range of organic compounds.
Used in Research Applications:
Methyl 4-amino-1,2,5-thiadiazole-3-carboxylate is also utilized in research settings, where its properties and reactivity are studied to better understand its potential applications and to develop new methodologies for its use in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 63875-18-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,8,7 and 5 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 63875-18:
(7*6)+(6*3)+(5*8)+(4*7)+(3*5)+(2*1)+(1*8)=153
153 % 10 = 3
So 63875-18-3 is a valid CAS Registry Number.
63875-18-3Relevant academic research and scientific papers
HERBICIDAL COMPOUNDS
-
Page/Page column 51; 52, (2016/11/17)
The present invention relates to herbicidal heteroaryl-alkyl-oxy-substituted heteroaryl/phenyl derivatives of formula (I), as well as to processes and intermediates used for the preparation of such derivatives. The invention further extends to herbicidal compositions comprising such derivatives, as well as to the use of such compounds and compositions in controlling undesirable plant growth;in particular the use in controlling weeds in crops of useful plants.
Angiotensin II receptor antagonists
-
, (2008/06/13)
Compounds are disclosed having the formula: STR1 wherein the substituents are defined herein. The compounds of the invention are angiotensin II receptor antagonists.
